11-8-17 9:54 AM EST | Email Article

GRAND PRAIRIE, Texas (AP) _ Neos Therapeutics Inc. (NEOS) on Wednesday reported a loss of $16.3 million in its third quarter.

On a per-share basis, the Grand Prairie, Texas-based company said it had a loss of 58 cents.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.

The pharmaceutical company posted revenue of $6.7 million in the period.

Neos Therapeutics shares have risen 83 percent since the beginning of the year. The stock has risen 95 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEOS at https://www.zacks.com/ap/NEOS

Add a Comment

Try Premium Membership today. Your first 14 days are free of charge. Start my Premium Membership Trial.
Sponsored Links
Buy a Link Now
Sponsor Center
Content Partners